The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health’s hepatology pipeline. LAVAL, QC, and CUPERTINO, CA … Read More
In health care environments, every touchpoint carries risk. Traditional high-touch surfaces — from elevator buttons to surgical monitors — can harbor pathogens and increase the risk of infection transmission. This… Read More
Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timeline to clinic Cytiva, a Danaher company and a global leader… Read More
The Northern Centre for Clinical Research (NCCR) has launched its first clinical trial at the University Hospital of Northern British Columbia (UHNBC) in Prince George, providing people in rural, remote and Indigenous… Read More
Developing and manufacturing innovative LNP delivery technology for respiratory medicine and beyond Expanding Evonik’s CDMO offerings, enabling efficient translation from concept to clinic Accelerating RNA-based therapeutic solutions for customers through… Read More
